Clinical Trial Update: Safety and Efficacy of Stem Cell Therapy in Patients With Autism [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of stem cell therapy in patients with autism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Stem cell therapy (stem cell)

Snippet

Sponsor: Shenzhen Beike Bio-Technology Co., Ltd. | Conditions: Autism | Phase 1, Phase 2 | Status: COMPLETED